GlaxoSmithKline Plc

Date: November 7, 2015
Pages: 69
Price:
US$ 175.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G91EBEC7A82EN
Leaflet:

Download PDF Leaflet

GlaxoSmithKline Plc
GlaxoSmithKline Plc - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

FEATURES:
  • Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis
  • An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments
  • Intelligence on GlaxoSmithKline Plc’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
HIGHLIGHTS:

GlaxoSmithKline (GSK or 'the company') is a leading global provider of pharmaceutical and consumer health-related products. The company primarily operates in the US, Europe, Asia-Pacific. GSK is headquartered in Brentford, the UK, and employed 99,451 people as on December 31, 2013.

REASONS TO PURCHASE:
  • Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on GlaxoSmithKline Plc’s business structure, strategy and prospects
Company Snapshot
  GlaxoSmithKline Plc: Company Overview
  GlaxoSmithKline Plc: Overview and Key Facts
    GlaxoSmithKline Plc: Overview
    GlaxoSmithKline Plc: Key Facts
  GlaxoSmithKline Plc: Key Employees
  GlaxoSmithKline Plc: Key Employee Biographies
  GlaxoSmithKline Plc: Major Products and Services
  GlaxoSmithKline Plc: Company History
  GlaxoSmithKline Plc: Management Statement
  GlaxoSmithKline Plc: Locations and Subsidiaries
  GlaxoSmithKline Plc: Key Competitors
GlaxoSmithKline Plc: Company Analysis
  GlaxoSmithKline Plc: Business Description
  GlaxoSmithKline Plc: SWOT Analysis
    GlaxoSmithKline Plc: SWOT Overview
    GlaxoSmithKline Plc: Strengths
    GlaxoSmithKline Plc: Weaknesses
    GlaxoSmithKline Plc: Opportunities
    GlaxoSmithKline Plc: Threats
  GlaxoSmithKline Plc: Corporate Financial Deals Activity
  GlaxoSmithKline Plc: Financial Deals Overview
  GlaxoSmithKline Plc: Targets and Partners
  GlaxoSmithKline Plc: Top Deals 2011 - 2015YTD
  GlaxoSmithKline Plc: Advisors
    GlaxoSmithKline Plc: Top Legal Advisors
    GlaxoSmithKline Plc: Top Financial Advisors
  GlaxoSmithKline Plc: Mergers and Acquisitions
  GlaxoSmithKline Plc: Corporate Venturing
  GlaxoSmithKline Plc: Capital Raising
  GlaxoSmithKline Plc: Partnership
  GlaxoSmithKline Plc: Divestments
GlaxoSmithKline Plc: Recent Developments
  GlaxoSmithKline Plc: News and Events Summary
  GlaxoSmithKline Plc: Business Expansion
  GlaxoSmithKline Plc: Contracts
  GlaxoSmithKline Plc: Red Flags/DistressSignals
  GlaxoSmithKline Plc: Regulatory and Legal Events
  GlaxoSmithKline Plc: Research & Development
Appendix
  Contact Us
  Methodology
  Definitions
  About Market Line

List of Tables

Table 1: GlaxoSmithKline Plc: Key Facts
Table 2: GlaxoSmithKline Plc: Key Employees
Table 4: GlaxoSmithKline Plc: Key Competitors
Table 5: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM)
Table 6: GlaxoSmithKline Plc: M&A Activity by Geography (TTM)
Table 7: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2011 - YTD2015)
Table 8: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Table 9: GlaxoSmithKline Plc: Targets and Partners
Table 10: GlaxoSmithKline Plc: Top Deals 2011 - 2015YTD
Table 11: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (US$m)
Table 12: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (US$m)
Table 13: GlaxoSmithKline Plc: M&A Volume and Value Trend (2011 - YTD2015)
Table 14: GlaxoSmithKline Plc: M&A Activity by Geography (2011 - YTD2015)
Table 15: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2011 - YTD2015)
Table 16: GlaxoSmithKline Plc: Corporate Venturing by Geography (2011 - YTD2015)
Table 17: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2011 - YTD2015)
Table 18: GlaxoSmithKline Plc: Capital Raising by Deal Type (2011 - YTD2015)
Table 19: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2011 - YTD2015)
Table 20: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2011 - YTD2015)
Table 21: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2011 - YTD2015)
Table 22: GlaxoSmithKline Plc: Divestments by Geography (2011 - YTD2015)
Table 23: GlaxoSmithKline Plc: News and Events Summary
Table 24: GlaxoSmithKline Plc: Business Expansion
Table 25: GlaxoSmithKline Plc: Contracts
Table 26: GlaxoSmithKline Plc: Red Flags/DistressSignals
Table 27: GlaxoSmithKline Plc: Regulatory and Legal Events
Table 28: GlaxoSmithKline Plc: Research & Development

List of Figures

Figure 1: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM)
Figure 2: GlaxoSmithKline Plc: M&A Activity by Geography (TTM)
Figure 3: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2011 - YTD2015)
Figure 4: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Figure 5: GlaxoSmithKline Plc: M&A Volume and Value Trend (2011 - YTD2015)
Figure 6: GlaxoSmithKline Plc: M&A Activity by Geography (2011 - YTD2015)
Figure 7: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2011 - YTD2015)
Figure 8: GlaxoSmithKline Plc: Corporate Venturing by Geography (2011 - YTD2015)
Figure 9: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2011 - YTD2015)
Figure 10: GlaxoSmithKline Plc: Capital Raising by Deal Type (2011 - YTD2015)
Figure 11: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2011 - YTD2015)
Figure 12: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2011 - YTD2015)
Figure 13: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2011 - YTD2015)
Figure 14: GlaxoSmithKline Plc: Divestments by Geography (2011 - YTD2015)
Skip to top


IMI plc: SWOT Analysis & Company Profile US$ 99.00 Nov, 2010 · 18 pages
Oakdene Homes Plc: SWOT Analysis & Company Profile US$ 125.00 Mar, 2010 · 16 pages
Galiform Plc.: SWOT Analysis & Company Profile US$ 125.00 Sep, 2010 · 16 pages

Ask Your Question

GlaxoSmithKline Plc
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: